Dementia will cost U.S. $818 billion this year, USC-led study finds
People with dementia and their families bear hidden costs — many of which are often overlooked.
USC Viterbi alumnus works to engineer trust in an AI-driven world
As artificial intelligence and automation transform our day-to-day lives, Kaustav Chakraborty is tackling the question in many people’s minds: How do we ensure that these systems are safe?
Anijo Mathew named dean of USC Jimmy Iovine and Andre Young Academy
The designer and entrepreneur comes to USC from the Institute of Design at Illinois Institute of Technology, where he serves as dean and professor.
Can AI be your therapist?: Q&A with USC Viterbi’s Ruishan Liu
The researcher is building evaluation methods for AI in healthcare. Her latest project asked 100 mental health professionals to stress-test AI chatbots on real patient questions.
Low-protein, amino acid-supplemented ‘longevity diet’ linked to longer healthy lifespan, lower frailty risk, better metabolic health
Animals fed the Mediterranean-inspired diet showed improved cardiometabolic markers.
Trojans co-develop framework to guide social media and AI accountability in courts
USC Marshall’s Neely Center contributes to a practical roadmap for crafting enforceable remedies in lawsuits targeting social media and generative AI companies.
Trojans commemorate Juneteenth with music, food and reflection
PHOTOS: Festivities make for lively morning in the International Plaza at the Ronald Tutor Campus Center.
AI is boosting productivity at home — but not equally
A study co-authored by USC Marshall’s Miao “Ben” Zhang is among the first to show that generative AI is delivering significant productivity gains outside the workplace — and that a growing digital divide threatens to leave older and lower-income Americans...
USC Roski Eye Institute marks golden anniversary with forward-looking symposium
The event highlighted research aiming to enhance the detection of eye diseases using AI and maps of the retina, alongside emerging science addressing macular degeneration, glaucoma, myopia and more.
USC-led team creates renewable cell source for cancer immunotherapy and beyond
Researchers develop a way to grow and genetically engineer the progenitor cells that give rise to macrophages, a type of first-responder immune cell that shows promise for developing immunotherapies for cancers and other diseases.
